Omada Health, Inc.
Company Stats
- Market Cap
- $1.3B
- as of Sep 30, 2026
- Shares Outstanding
- 61.2M
- Free Float
- 86.8%
Income Statement
- Revenue
- $260.2M
- Operating Income
- -$12.0M
- Net Income
- -$12.8M
- EBITDA
- -$6.5M
- FCF Margin, 3Y Avg
- -18.3%
- FCF Margin, Worst Year
- -40.8%
Cash Flow
- Free Cash Flow
- $16.9M
- FCF Yield
- 1.3%
- Owner FCF Yield
- 0.3%
Balance Sheet
- Cash & Equivalents
- $222.0M
Returns & Capital
- SBC, 3Y Avg
- $10.4M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $260.2M | $16.9M | 6.5% |
| FY2024 | $169.8M | -$34.8M | -20.5% |
| FY2023 | $122.8M | -$50.2M | -40.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 1, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Earnings
Other Coverage
October 14, 2026
Theme Survey
GLP-1 companies reshape access and detail treatment dropouts
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 4, 2026
Theme Survey
GLP-1 Shift: Branded Access and Oral Formulations Gain Ground
GLP-1 companies reshape access and detail treatment dropouts
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 4, 2026
Theme Survey
GLP-1 Shift: Branded Access and Oral Formulations Gain Ground